Dysregulations of LRRFIP1/GCF2 play broad and critical roles in the development of human diseases such as infections and autoimmune diseases, neurological, cardiovascular, metabolic diseases and cancer. This evidence concerns the gene LRRFIP1 and Other metabolic disease.